Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 billion. The acquisition – which was confirmed to be in the final stages ...

Merck & Co's earlier efforts to find new therapies for Alzheimer's disease resulted in failure, but the company is returning to the field via an R&D alliance with UK biotech Cerevance that will ...

View the latest Merck KGaA (MRK) stock price, news, historical charts, analyst ratings and financial information from WSJ.

See the latest Merck & Co Inc stock price (MRK:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

Get the detailed quarterly/annual income statement for Merck & Co., Inc. (MRK). Find out the revenue, expenses and profit or loss over the last fiscal year.

Review the current Merck & Co Inc (MRK:XNYS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if MRK is the best investment for you.

Merck & Co Share Price Live Today:Get the Live stock price of MRK Inc., and quote, performance, latest news to help you with stock trading and investing.Check out why Merck & Co share price is up ...

Get the annual and quarterly balance sheet of Merck & Co., Inc. (MRK) including details of assets, liabilities and shareholders' equity.

With this new investment, Merck said it is eyeing to provide comprehensive material solutions for local customers and partners with strengthened local capabilities and a faster response to market, to ...